J9204 Injection mogamulizumab-kpkc, 1 milligrams
J-Codes
Also known as: mogamulizumab, Poteligeo
Intravenous injection of mogamulizumab-kpkc, a defucosylated humanized monoclonal antibody targeting CC chemokine receptor 4 (CCR4), dosed per 1 milligram.
Clinical Context
Used for mycosis fungoides and adult T-cell leukemia-lymphoma expressing CCR4.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.